Human papillomavirus (HPV) infections are generally long lasting, and a host immune
response to infection is hard to detect. Nevertheless immunocompromised subjects control …

Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus
infection is harmless and clears spontaneously but persistent infection with high-risk human …

Human papillomavirus (HPV) types cause approximately 70% of cervical cancer worldwide.
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …

The focus of Berek and Hacker's for four editions has been on the application of basic and
clinical science to the clinical practice of gynecologic oncology. That approach has been …

Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic …

Objectives (1) To synthesize sociocultural results from diverse populations related to vaccine
decision-making, understanding of cervical cancer and its etiology, experience with previous …

Background: Cervical cancer incidence in western Africa is among the highest in the world.
Methods: To investigate human papillomavirus (HPV) infection in Guinea, we obtained …

Many countries are considering vaccination against human papillomavirus (HPV). However,
the long-term impact of vaccination is difficult to predict due to uncertainty about the …

Abstract Background The Human Papillomavirus (HPV) is generally recognized to be the
direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in …

Cervical cancer is a major cause of suffering and premature death among women in the
developing world, yet it is largely prevented in most higher-income countries. From an equity …